Buy the Pullback in LeMaitre: Acquisition Optionality and Margin Leverage Look Underpriced
LeMaitre Vascular (LMAT) dipped after a near-term earnings disappointment, yet the company sits on a capital structure and margin momentum that should accelerate M&A-driven growth. With a market cap near $1.89B, free cash flow of roughly $73.8M, and prior authorization for a $100M repurchase plus a $150M convertible note shelf, LMAT can both buy ba…